Clinical Trials Browser

Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

Clinical Trials

MK-7339-007

China Phase II

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Ribociclib (LEE011) Rollover Study for Continued Access

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

EXPAND-1

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors

A Monotherapy in Subjects With Advanced Solid Tumors

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

RAGNAR

A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

A Study YL201 in Patients With Selected Advanced Solid Tumors

A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors

A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Tremelimumab

A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors

KEYNOTE-603

Study of E7389 Liposomal Formulation in Participants With Solid Tumor

QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours

Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial

A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors

Study of GS-4528 in Adults With Solid Tumors

A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors